Actively Recruiting
Attention Deficit Hyperactivity Disorder
Led by Nantes University Hospital · Updated on 2026-04-17
80
Participants Needed
3
Research Sites
142 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The ADA cohort aims for the systematic and standardized collection of sociodemographic, clinical and neuropsychological data, during 2 visits (inclusion and 12 months), from patients suffering from the co-occurrence of ADHD (Attention Deficit Hyperactivity Disorder) and addiction(s), in addition to the treatment as usual adapted to each situation.
CONDITIONS
Official Title
Attention Deficit Hyperactivity Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged over 18 years
- Diagnosis of ADHD confirmed less than 12 weeks ago
- Diagnosis of one or more addictive disorder(s) confirmed
- Meeting indication for methylphenidate (MPH) treatment according to European recommendations
- Patients who have not yet started MPH treatment but can benefit from it
- Affiliated with social security
You will not qualify if you...
- Disorders of higher cognitive functions preventing data collection
- Difficulties in reading or writing French preventing data collection
- Unable to commit to availability for the two planned study visits
- Under guardianship or legal protection
- Use of psychoactive substances within 12 hours prior to study visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Nantes University Hospital
Nantes, Loire-Atlantique, France, 44093
Actively Recruiting
2
CHRU de Brest
Brest, France, 29000
Actively Recruiting
3
CHRU de Tours
Tours, France, 37000
Actively Recruiting
Research Team
C
Clémence CABELGUEN, PH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here